Medindia

X

NHS To Continue Providing Alzheimer's Drugs

by Medindia Content Team on  January 23, 2006 at 1:06 PM Mental Health News   - G J E 4
NHS To Continue Providing Alzheimer's Drugs
The NHS will continue to provide crucial drugs to patients who suffer from moderate dementia, according to the revised plans which have been unveiled. There were protests from campaigners and doctors earlier when the National Institute for Health and Clinical Excellence (NICE) had announced that Alzheimer's drugs were no longer cost effective, and the NHS will not provide them. As many as three drugs have been recommended by the Appraisal Committee of the NHS which will be provided to people suffering from the disease.
Advertisement

The cholinesterase inhibitors called the rivastigmine, galantamine, donepezil, and memantine can serve to alleviate Alzheimer's symptoms, but they are not considered cost effective by the NHS, as its per day cost is at £2.50 per patient. Memantine which provides relief in the latter stages is not one among the three drugs contemplated by the NHS, according to the revised plan. The UK has a total of 72,000 people who suffer from the milder form of Alzheimer's, while another 309,000 fall under the category known as moderate to severe. The new guidelines are expected to be published in 2006, and it will be applicable to patients who have been recently diagnosed.

Advertisement
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All